User profiles for S. Kavanagh

Sarah Schneider Kavanagh

- Verified email at upenn.edu - Cited by 2343

Shane Kavanagh

- Verified email at its.jnj.com - Cited by 2172

Sam Kavanagh

- Verified email at aucklanduni.ac.nz - Cited by 942

A systematic review of virtual reality in education

S Kavanagh, A Luxton-Reilly, B Wuensche… - Themes in science …, 2017 - learntechlib.org
… As many of the implementations analyzed were designed to simulate real world learning
experiences, the user’s physical location is largely irrelevant. Distance learning can allow …

Silver nanoparticles in the environment: Sources, detection and ecotoxicology

E McGillicuddy, I Murray, S Kavanagh… - Science of the Total …, 2017 - Elsevier
The environmental impact of silver nanoparticles (AgNP) has become a topic of interest
recently, this is due to the fact that AgNPs have been included in numerous consumer products …

Evidence suggests a need to rethink social capital and social capital interventions

A Shiell, P Hawe, S Kavanagh - Social science & medicine, 2020 - Elsevier
In the 21 years since social capital first appeared in the public health literature, the evidence
base has grown enormously, now reaching 28 systematic reviews encompassing more than …

Core practices and pedagogies of teacher education: A call for a common language and collective activity

…, E Kazemi, SS Kavanagh - Journal of teacher …, 2013 - journals.sagepub.com
… Each wave has been closely tied to each era’s predominant conceptual lens for
understanding teaching and learning. In the 1960s and 1970s, when research on teaching was …

[HTML][HTML] Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial

…, PB Shieh, S Kavanagh, S Tauscher-Wisniewski… - Nature medicine, 2022 - nature.com
SPR1NT ( NCT03505099 ) was a Phase III, multicenter, single-arm study to investigate the
efficacy and safety of onasemnogene abeparvovec for presymptomatic children with biallelic …

[HTML][HTML] Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial

…, S Kavanagh, M Wigderson, S Tauscher-Wisniewski… - Nature medicine, 2022 - nature.com
Most children with biallelic SMN1 deletions and three SMN2 copies develop spinal muscular
atrophy (SMA) type 2. SPR1NT ( NCT03505099 ), a Phase III, multicenter, single-arm trial, …

Cation disorder engineering yields AgBiS2 nanocrystals with enhanced optical absorption for efficient ultrathin solar cells

Y Wang, SR Kavanagh, I Burgués-Ceballos, A Walsh… - Nature …, 2022 - nature.com
… The valence band maximum (VBM) of AgBiS 2 primarily derives from Ag d and S p states, …
These XRD peak shifts primarily originate from the shortening of the Ag–S bond lengths, …

[HTML][HTML] Strong absorption and ultrafast localisation in NaBiS2 nanocrystals with slow charge-carrier recombination

YT Huang, SR Kavanagh, M Righetto, M Rusu… - Nature …, 2022 - nature.com
… On the other hand, we see a much less disperse ‘bulk’ VBM with only small Bi s contributions,
and the emergence of flat, localised S p states just above this ‘bulk’ VBM. The weak …

Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: the MIRROR study

…, EW Lewis, FJ Derosier, MC Lopez, ST Kavanagh… - Neurology, 2018 - AAN Enterprises
… Lopez, and S. Kavanagh were employees of/stockholders in GlaxoSmithKline at the time
of this study. A. Miller has served as a consultant or a member of the scientific advisory board …

[HTML][HTML] Perovskite-inspired materials for photovoltaics and beyond—from design to devices

YT Huang, SR Kavanagh, DO Scanlon, A Walsh… - …, 2021 - iopscience.iop.org
… Yi-Teng Huang 1 , Seán R Kavanagh 2,3,4 , David O Scanlon 2,4,5 , Aron Walsh 3,6 and …
Any further distribution of this work must maintain attribution to the author(s) and the title of the …